Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP

Last updated on 2020-03-25 History
Report ID 105189
Drug Identification Number 02139510
Brand name SODIUM CHLORIDE INJECTION, USP
Common or Proper name Sodium Chloride Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 234MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-31
Estimated end date 2020-04-20
Actual end date 2020-03-24
Shortage status Resolved
Updated date 2020-03-25
Company comments Our Sodium Chloride Injection, USP PBP Vial 200mL will be available for substitution, and allocations of Sodium Chloride Injection 200mL vial have been increased to cover the Sodium Chloride 100mL demand.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-03-25 English Compare
v4 2020-03-24 French Compare
v3 2020-03-24 English Compare
v2 2020-02-03 French Compare
v1 2020-02-03 English Compare